Easy Bio Inc

Easy Bio Inc maintains a debt-to-equity ratio of 1.43, indicating a moderate reliance on debt financing, while its current ratio of 1.35 suggests adequate short-term liquidity to meet obligations. The company's liquidity position is assessed as medium, with free cash flow of 24,610,341,270 KRW and operating cash flow of 34,653,612,540 KRW, but net cash is negative after subtracting total debt. Profitability metrics show a return on equity of 25.91% and a return on assets of 8.48%, both exceeding typical thresholds for the industry, indicating strong capital efficiency and asset utilization. The company's operating income of 44,989,797,480 KRW and net income of 27,777,669,010 KRW reflect robust earnings performance relative to its revenue of 476,938,919,230 KRW. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration is inferred to be within the Food & Beverages sector, with no disclosed diversification across multiple geographic regions or business lines. Growth trajectory is supported by a positive outlook, with analysts estimating a mean revenue of 514,000,000,000 KRW compared to the actual 476,939,000,000 KRW, suggesting a projected increase in revenue. The company's capital expenditure of -6,303,198,710 KRW indicates a reduction in investment, which may signal a shift in strategic focus or a response to market conditions. Risk factors include a medium liquidity risk and a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. The company's risk assessment highlights the need to monitor its debt position, as net cash is negative after subtracting total debt. Recent events include the publication of financial data and analyst estimates, with the last actual EPS reported at 840.00 KRW and the mean EPS estimate at 1,236.00 KRW, indicating a positive earnings outlook.